{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:22:57Z","timestamp":1789845777029,"version":"4.0.1"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11,1]]},"DOI":"10.2146\/news120072","type":"journal-article","created":{"date-parts":[[2012,10,31]],"date-time":"2012-10-31T06:01:30Z","timestamp":1351663290000},"page":"1846-1846","source":"Crossref","is-referenced-by-count":1,"title":["New kinase inhibitor approved for CML"],"prefix":"10.1093","volume":"69","author":[{"given":"Kate","family":"Traynor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/69\/21\/1846\/28361997\/ajhp1846.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T00:05:22Z","timestamp":1555113922000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/69\/21\/1846\/5112057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,1]]},"references-count":0,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2012,11,1]]}},"URL":"https:\/\/doi.org\/10.2146\/news120072","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,11,1]]},"published":{"date-parts":[[2012,11,1]]}}}